Imclone lost its separate identity in 2014 when its former ImClone research and manufacturing sites were renamed Eli Lilly and Company. ImClone's stock...

Exchange Commission and U.S. Attorney probe into trading in the shares of ImClone Systems resulted in a widely publicized criminal case, which resulted in prison...

1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder of Kadmon Pharmaceuticals, which was financed...

2012. In 2004, Stewart was convicted of felony charges related to the ImClone stock trading case; she served five months in federal prison for fraud...

such as those affecting Enron, Tyco International, Adelphia, Peregrine Systems and WorldCom, when the concept was strongly emphasized in the Sarbanes–Oxley...

was founded in 2009 by Samuel D. Waksal, founder and former CEO of ImClone Systems, a company now fully merged into Eli Lilly. Waksal had served a federal...

Aventis/Imclone case" (PDF). Archived from the original (PDF) on 27 September 2011. Retrieved 25 May 2012. "Yeda Research v. Imclone Systems, et al"....

designed for the treatment of solid tumors. Icrucumab was developed by ImClone Systems Inc. It is undergoing Phase I trials. "Statement On A Nonproprietary...

drug by the pharmaceutical company ImClone Systems, Inc. Paul Goldberg documented the missteps in FDA filings by ImClone that led to the failure to secure...

Internet Icahn Enterprises conglomerates Iconix Brand Group fashion ImClone Systems pharmaceuticals ImpreMedia media Infor software Inner City Broadcasting...

Technologies, Inc. (Acq 1992) PCS System (Acq 1994) Icos Corporation (Acq 2007) Hypnion, Inc (Acq 2007) ImClone Systems (Acq 2008) SGX Pharmaceuticals,...

developed for the treatment of solid tumors. This drug was developed by ImClone Systems Inc. It was isolated from a native phage display library from Dyax...

Waksal is the founder and former CEO of the biopharmaceutical company ImClone Systems. In October 2002, he pleaded guilty to charges of securities fraud...

IMCL may refer to: Indian Made Country Liquor or Desi daru ImClone Systems This disambiguation page lists articles associated with the title IMCL. If...

with Samuel D. Waksal, the founder of the bio-pharmaceutical company ImClone Systems, who spent five years in federal prison for securities fraud. LaBeouf...

Memphis Grizzlies Samuel D. Waksal (1947–), French-born founder of ImClone Systems, Kadmon Corporation Herbert Wertheim (1939–), founder of eye care products...

Hachette Filipacchi Media U.S. Harden Furniture R.H. Hooper & Company ImClone Systems Kahr Arms Kaplan, Inc. Kaye Scholer KPMG Lehman Brothers Loehmann's...

2006, he was the senior vice president, general counsel and CCO of ImClone Systems, a Nasdaq-100 biotechnology firm, which was later acquired by Eli Lilly...

development was abandoned after phase I trials. Narnatumab was developed by ImClone Systems. "Statement On A Nonproprietary Name Adopted By The USAN Council: Narnatumab"...

treatment of melanoma. It targets TYRP1. Flanvotumab was developed by ImClone Systems, now owned by Eli Lilly. "Statement On A Nonproprietary Name Adopted...

obstruction of justice, and lying to an FBI agent. She sold 3,928 shares of ImClone Systems, thereby avoiding a loss of $45,673. The next day, the Food and Drug...

antibody for the treatment of solid tumors. This drug was developed by ImClone Systems, since acquired by Eli Lilly, using phage display technology from Dyax...

Archived from the original on April 6, 2012. Retrieved November 1, 2011. "Ex-ImClone boss admits fraud". BBC News. October 15, 2002. Archived from the original...

biological half-life of 11 days. Olaratumab was originally developed by ImClone Systems, which was acquired by Eli Lilly in 2008. A Phase I clinical trial...

Nobel prize. However the dissimilarity between murine and human immune systems led to the clinical failure of these antibodies, except in some specific...

selection: Elusys Therapeutics: Chairman, 2000–2007; Director, 2007–2009 ImClone Systems: Director, 1996–2007 Isis Pharmaceuticals: Director, 1994–2000 SIBIA...

was CEO from February 2011 until February 2012, formerly employed by Imclone Systems. Savient declared bankruptcy in 2013. The drug was selling at $5,390...

included WorldCom Inc., Tyco International Ltd., Vivendi Universal SA and ImClone Systems Inc. In 2018, she won the Lifetime Achievement Award from the Gerald...

Molecular cloning is a set of experimental methods in molecular biology that are used to assemble recombinant DNA molecules and to direct their replication...

worldwide, apart from North America. (Cetuximab was discovered by Imclone Systems, and is marketed in North America by Bristol-Myers Squibb.) Other areas...